Although we have not shown direct evidence for this, reduced expression of CYLD may fail to negatively regulate NF-κB signalling pathways, thus promoting an inflammatory mechanism in sIBM pathogenesis. The gene discussed is NFKB1; the disease is inclusion body myositis.